120277-15-8

Basic information

• Product Name: 4-(broMoMethyl)-2-Methoxypyridine
• Synonyms: 4-(broMoMethyl)-2-Methoxypyridine
• CAS NO: 120277-15-8
• Molecular Formula: C₇H₈BrNO
• Molecular Weight: 202.04852
• Mol File: 120277-15-8.mol

Chemical Properties

• Boiling Point: 250.2±25.0 °C(Predicted)
• Appearance: /
• Density: 1.484±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 2.99±0.10(Predicted)
• CAS DataBase Reference: 4-(broMoMethyl)-2-Methoxypyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(broMoMethyl)-2-Methoxypyridine(120277-15-8)
• EPA Substance Registry System: 4-(broMoMethyl)-2-Methoxypyridine(120277-15-8)

Safety Data

• Hazardous Substances Data: 120277-15-8(Hazardous Substances Data)

Usage

Uses

Used in Organic Chemistry:
4-(BromoMethyl)-2-Methoxypyridine is used as a key intermediate in the synthesis of a variety of organic compounds. Its unique structure allows it to participate in numerous chemical reactions and transformations, making it a valuable component in organic chemistry research and development.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-(BromoMethyl)-2-Methoxypyridine is utilized as a precursor in the production of various drugs. Its reactivity and functional groups enable the creation of new pharmaceutical entities that can address a range of health conditions.
Used in Agrochemical Production:
4-(BromoMethyl)-2-Methoxypyridine also finds application in the agrochemical sector, where it serves as an intermediate in the synthesis of pesticides and other crop protection agents. Its role in these processes contributes to the development of effective and targeted agrochemicals.
Used in the Synthesis of Fine Chemicals:
4-(broMoMethyl)-2-Methoxypyridine is also employed in the synthesis of fine chemicals, which are high-purity chemicals used in various industries, including fragrances, flavors, and specialty chemicals. The versatility of 4-(BromoMethyl)-2-Methoxypyridine makes it suitable for creating a wide array of fine chemicals with specific applications.

Upstream product

• 123148-66-3 2-methoxy-4-(hydroxymethyl)-pyridine 
• 26156-51-4 methyl 2-methoxyisonicotinate 
• 105596-63-2 2-methoxy-isonicotinic acid 

Downstream Products

• 1361225-28-6 2-((2-methoxy-4-pyridinyl)methyl)piperazine 
• 1361225-30-0 1,1,1,3,3,3-hexafluoro-2-(4-(2-((2-methoxy-4-pyridinyl)methyl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)phenyl)-2-propanol 

Relevant articles and documents

Azacycle diketone compound and preparation method thereof (by machine translation)

The invention provides a azacyclodiketone compound which is characterized by being a compound represented by the following structure. The compound has inhibitory activity on cap-dependent endonuclease. (by machine translation)

OX2R COMPOUNDS

Methods and compositions for agonizing a type-2 orexin receptor (OX2R) in a cell determined to be in need thereof, including the general method of (a) administering to a subject a cyclic guanidinyl OX2R agonist and (b) detecting a resultant enhanced wakefulness or increased resistance to diet-induced accumulation of body fat, or abbreviated recovery from general anesthesia or jet lag.

Substituted Pyrrolidine Amides I

The invention relates to compounds according to general formula (I), which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.

N-methyl tetrahydroquinoline M1 receptor positive allosteric modulators

The present invention is directed to N-methyl tetrahydroquinoline compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor.

SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES

The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

QUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS

The present invention is directed to quinoline amide compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor.